Investigative Report · October 29, 2026
Winter Came Early
The 2026-27 flu season arrived six weeks ahead of schedule, driven by a virus no one was watching, and met a system thinner than at any point in a decade.

This investigates a headline that was half right. Winter did come early. The reason given for it was wrong, and the real reasons to worry were left out.
In the last week of October 2026, New York declared influenza prevalent, a legal designation it usually makes in December. Coverage attributed the early arrival to the “superflu,” last winter’s H3N2 subclade K. The surveillance record says otherwise: of 241 influenza A viruses subtyped in the week ending October 17, 239 were H1N1 and none were H3N2. The virus driving the season carries a single mutation, G155E, that appears to slip past the immunity of teenagers and young adults. National activity remains low. The danger this report documents is not the virus but where it lands.
Investigative report by Kelly Emrick, 39 pages, 14 figures, 8 tables, 111 references. This page rebuilds its evidence as an interactive dashboard and adds two working tools: a peak-week cost model and the EARLY Readiness Model scorer.
The season at a glance
Five findings
- The declaration came 44 days early. New York’s October 26 declaration preceded its 2025-26, 2024-25, and 2023-24 declarations by 37, 53, and 41 days, with no case figures published alongside it. It activated a standing regulation requiring unvaccinated health care workers to mask.
- The villain was wrong. The circulating virus is A(H1N1)pdm09, not last winter’s subclade K, which accounted for 2.0 percent of subtyped viruses cumulatively. A new mutation, G155E, first flagged in Seattle in September, was present in 13 of 17 H1N1 samples sequenced at the University of Washington.
- Early does not mean severe. Outside the 2009 pandemic, US seasons since 1982-83 have almost never peaked before December, CDC’s September outlook rated a severe season no more likely than usual, and Australia’s 2026 winter ran well below its 2025 record.
- The real exposure is structural. Flu vaccination coverage of 51.4 percent in children and 64.4 percent in adults 65 and older, a CDC civil service down about 30 percent, three canceled ACIP meetings and no new federal flu recommendation, and measles at 4,588 cases, double the 2025 record.
- Hospitals have no slack. Mean occupancy near 75 percent, 16 percent fewer staffed beds than the 2009-2019 average, 30 percent fewer pediatric units than 2008, and more than half of admitted emergency patients boarding four hours or longer. A moderate season is enough to break a system with no slack.
The report’s judgment
The virus is probably ordinary. The system is not. The policy response to an ordinary virus arriving at an extraordinary moment is readiness, measured and repeated, not alarm.
Section 11, The Strongest Case Against This Report
1. The Declaration
The New York State Department of Health’s October 26, 2026 press release was, on its face, an announcement about a website. In the same release, Commissioner James V. McDonald declared influenza prevalent across the state, said the season was “starting earlier than usual,” and noted that flu vaccination doses reported to the State were lower than in previous years. The release included no case counts, hospitalization figures, or mention of any strain or variant.
How much earlier than usual? The release did not say, so the report reconstructed the answer from the State’s prior declarations. Against the three preceding seasons, the 2026 declaration came 37, 53, and 41 days earlier, averaging 44 days, or just over six weeks. The phrase “six weeks early” is defensible, but it is arithmetic from declaration dates, not a figure any official published.
Source: NYS DOH press releases, Dec 28, 2016; Dec 6, 2023; Dec 18, 2024; Dec 2, 2025; Oct 26, 2026. Average of the three preceding seasons is December 9.
What “prevalent” triggers
The designation is a regulatory switch, not a severity rating. Under 10 NYCRR 2.59, regulated hospitals, nursing homes, and home care agencies must ensure personnel who have not received the current season’s flu vaccine wear a surgical or procedure mask wherever patients or residents may be present, for as long as the declaration stands. In prior seasons the trigger came in December, after weeks of steep increases: hospitalizations nearly doubled week over week before the 2025 declaration and rose 48 percent before the 2024 one. This year it came in October, with no numbers.
What the numbers do show
By news accounts citing the new State dashboard, New York recorded 3,526 laboratory-confirmed cases in the week ending October 17, up from 668 a year earlier, and 233 hospitalizations, up from 46, with cases in 59 of 62 counties. The following week cases rose 19 percent and hospitalizations 17 percent. Real increases from a low base: in the week ending December 20, 2025, the state recorded 71,123 cases, the most in any week since flu became reportable in 2004. October’s numbers are roughly one twentieth of last winter’s peak.
The national picture in the week before the declaration
| Indicator | Week 41, 2026 (ending Oct 17) | Context |
|---|---|---|
| Outpatient visits for influenza-like illness | 2.2% | Below the 2.9% national baseline; higher than the prior two seasons at this point |
| Clinical lab positivity | 5.7% (2,918 of 51,490) | Under 1% in the same week of 2025 |
| Subtyped influenza A viruses | 239 H1N1, 0 H3N2, 2 H5 (n = 241) | Cumulative since Oct 4: 97.7% H1N1, 2.0% H3N2 |
| FluSurv-NET weekly hospitalization rate | 1.1 per 100,000 | Highest Week 41 rate since 2010-11 |
| FluSurv-NET cumulative rate | 2.1 per 100,000 | Last season ended at 87.2 per 100,000 |
| Jurisdictions at high or very high activity | 0 | Louisiana and Hawaii at moderate |
| Pediatric deaths, 2026-27 | 0 | 198 reported for 2025-26 as of Oct 9 |
| States with growing or likely growing infections | 44 | CDC estimate as of Oct 21 |
Table 1 in the report. Sources: CDC FluView Week 41 and Week 39; Becker’s Hospital Review, Oct 26, 2026.
Source: CDC FluView Weeks 39 and 41, 2026; Axios, Oct 9, 2026. The 2025 Week 41 value is reported as under 1 percent.
New York is not alone
2. The Wrong Villain
This season’s story began with a true story from last season. In June 2025, after the strains for the 2025-26 vaccine had been chosen, a drifted H3N2 variant, formally J.2.4.1 and informally subclade K, was first detected in New York. It carried 11 changes in the hemagglutinin protein relative to the vaccine strain, eight at antibody-binding sites, and spread through Japan, Hong Kong, and the United Kingdom before reaching the United States in force around Thanksgiving. By season’s end it accounted for 93 percent of all characterized H3N2 viruses in the country. The label “superflu,” which Nicola Lewis of the Francis Crick Institute told Gavi is not a scientific term, stuck anyway.
That history made it the obvious suspect when flu returned early in 2026. It is the wrong suspect. CDC’s public health laboratory data show H3N2 at 16 of 798 subtyped viruses cumulatively, 2.0 percent, and zero of 241 in Week 41. Subclade K is the dominant form of H3N2 wherever H3N2 appears: 89 of 94 characterized H3N2 viruses belong to it. But a 94.7 percent share of a 94-virus denominator within a subtype that is 2 percent of detections does not show a subclade K season. It shows subclade K is still around and H1N1 is in charge.
Source: CDC FluView, Week 41, 2026. Of the 94 H3N2 viruses genetically characterized this season, 89 (94.7%) were subclade K; of 317 H1N1 viruses, 316 were subclade D.3.1.1.
Why the error traveled so far
CDC’s own 2026-27 vaccine announcement noted that the H3N2 component was changed to protect against “the influenza A(H3N2) subclade K virus that spread widely during the 2025-2026 season,” keeping the name in circulation.
Australia’s 2026 winter, the Northern Hemisphere’s usual preview, was reported in September as a subclade K season, before H1N1 overtook H3N2 in at least two Australian states by mid-October.
Early local reporting in New York referred to a “new strain” without naming it, and a familiar name filled the gap.
Why the distinction matters
H3N2 seasons and H1N1 seasons hurt different people. H3N2 seasons typically produce higher hospitalization rates among older adults; last winter adults 65 and older were hospitalized at 274.2 per 100,000. H1N1, the lineage of the 2009 pandemic, has historically fallen hardest on younger people, and the current mutation appears to sharpen that tilt. A hospital that prepares for a repeat of last winter prepares for the wrong patients.
Subclade K and the current H1N1, side by side
| Feature | H3N2 subclade K (J.2.4.1) | H1N1pdm09 D.3.1.1 with G155E |
|---|---|---|
| First detected | New York, June 2025; WHO dates global emergence to August 2025 | Japan as early as May 2026; flagged in Seattle in September 2026 |
| Season it drove | 2025-26 (86.6% of subtyped A; 93% of characterized H3N2) | 2026-27 to date (99.2% of subtyped A in Week 41) |
| Immune escape | 11 hemagglutinin changes; 3- to 8-fold lower neutralizing antibodies | Single substitution at position 155; teens and young adults recognize it poorly (preprint) |
| Population most affected | Children 5-17 (record rate) and adults 65+ | Early signals point to teenagers and young adults |
| Vaccine match | Mismatched; VE 35-38% in US children, 37% in Canada vs. K | Unknown until midwinter; 93.2% of isolates still recognized by vaccine antisera |
| Severity per infection | CDC: “no evidence” of more severe illness | No severity claim from any laboratory |
3. The Mutation That Matters
The virus driving the season is A(H1N1)pdm09, subclade D.3.1.1, which accounted for 316 of 317 H1N1 viruses the CDC characterized genetically this season. Within it, a single amino acid substitution at position 155 of the hemagglutinin protein, glycine to glutamic acid, has drawn the attention of leading influenza laboratories. Japan’s national infectious disease institute detected the mutation as early as May 2026 and watched it spread from August; by the week ending October 4, Japanese clinics were seeing about 11 flu patients each, roughly seven times the prior year’s rate, and schools were closing. In Seattle, Alex Greninger’s laboratory at the University of Washington found G155E in 13 of 17 H1N1 samples complete enough to sequence.
The evidence
A bioRxiv preprint led by Jesse Bloom at Fred Hutchinson Cancer Center tested blood from 260 people in Australia and the United States against 148 influenza A viruses circulating by mid-2026. In some cases strains carrying G155E were recognized less well by existing antibodies, and antibodies from teenagers and young adults recognized the variant especially poorly. The preprint is not peer-reviewed, and its authors say so.
The explanation
Samuel Scarpino of Northeastern University explains the pattern through immune imprinting: the first influenza strain a person meets shapes the antibodies they rely on for life. For people born in the early 2000s or later, that first H1N1 was likely the 2009 pandemic strain or its descendants. The mutation “hits a spot” those immune systems tend to focus on. People imprinted by the older seasonal H1N1 that circulated from 1977 to 2009 carry a broader repertoire that G155E disturbs less.

Vaccine match: less immunity, not no immunity
“A mismatch is not a black-or-white situation. We may have less immunity, not no immunity.”
“This is one of those seasons where the key message is to go get vaccinated now.”
Bloom told Nature that if the mutation comes to dominate, the H1N1 component of this year’s vaccine may be poorly matched, and that it is too early to know. Scott Hensley of the University of Pennsylvania said the H3N2 and influenza B components appear well matched. CDC’s antigenic testing offers reassurance: 93.2 percent of H1N1 isolates characterized this season remained well recognized by antisera raised against the 2026-27 vaccine reference virus. Officials will not have vaccine effectiveness data until midwinter.
Three operational facts
The population most exposed is not the one hospitals traditionally brace for in flu season.
Vaccine effectiveness will not be known until midwinter, which argues for treating every high-risk patient as unprotected and treating early.
Greninger has warned that a second, more conventional wave of H3N2 or influenza B could follow once H1N1 peaks, shifting the burden back toward older adults in the depths of winter. The vaccine was updated specifically for that H3N2. The early season may be the first of two.
4. What Last Winter Taught
The 2025-26 season is the reference point against which every October number is being read. By CDC’s preliminary estimates it caused at least 32 million illnesses, roughly 390,000 hospitalizations, and 24,000 deaths. Those are large numbers. They are also well below the 710,000 hospitalizations and 45,000 deaths of 2024-25, which CDC classified as high severity in every age group. CDC rated 2025-26 moderate overall, and high only for children.
Source: CDC Past Seasons Estimated Influenza Disease Burden; CDC 2024-25 season summary; CDC FluView Week 20, 2026. 2020-21 omitted (minimal activity). 2025-26 figures are in-season estimates through May 2026. Red marks CDC high-severity seasons.
View the published figure from the report

Speed
Hospitalizations began rising in mid-November and peaked in the week ending December 27, 2025, when the FluSurv-NET weekly rate hit 12.8 per 100,000, the second-highest peak week since 2010-11, and 33,301 patients were admitted with laboratory-confirmed flu in a single week as first reported (later revised above 40,000). Outpatient visits for influenza-like illness reached 8.2 percent that week.
Who got sick
Children 5 to 17 had the highest cumulative hospitalization rate since FluSurv-NET began in 2010-11, children under 5 the second highest, and the pediatric peak week of 7.3 per 100,000 was the highest since 2010-11. As of October 9, 2026, 198 pediatric deaths had been reported for the season, with late reports still arriving.
Source: CDC FluView Week 17, 2026; Budd, CDC, National Adult and Influenza Immunization Summit, May 19, 2026.
The hospital record from that peak
The vaccine helped less than usual and more than nothing
CDC’s interim estimates put effectiveness against H3N2 in children at 35 percent for outpatient illness and 38 percent against hospitalization; the adult outpatient estimate of 11 percent was not statistically different from zero. Canada’s sentinel network estimated 37 percent against subclade K specifically. The United Kingdom reported 70 to 75 percent protection against hospital attendance in children and 30 to 40 percent in adults. The vaccine strain, chosen before subclade K was identified, was antigenically distinct from it. It still cut severe disease in the group that needed it most.
Source: Maloney et al., MMWR, Mar 12, 2026; Skowronski et al., Eurosurveillance, Feb 5, 2026; UKHSA, Nov 11, 2025. Bars show point estimates; whiskers show 95% confidence intervals (UK figures are reported ranges). The adult US estimate is not statistically significant.
View the published figure from the report

Last winter and this autumn, side by side
| Measure | 2025-26 season | 2026-27 to date (Week 41) |
|---|---|---|
| Predominant virus | A(H3N2), 86.6% of subtyped A; 93% subclade K | A(H1N1)pdm09, 99.2% of subtyped A in Week 41 |
| Season onset | Mid-November rise | Late August rise on the Pacific coast; positivity above 3% by late September |
| Peak week | Week ending Dec 27, 2025 (12.8 per 100,000) | Not yet reached |
| Cumulative FluSurv-NET rate | 87.2 per 100,000 (third highest since 2010-11) | 2.1 per 100,000 |
| Severity (CDC) | Moderate overall; high in children | Not rated; outlook expects moderate |
| Pediatric deaths | 198 reported (as of Oct 9, 2026) | 0 |
| Hospitalizations | About 390,000 | 4,811 admissions in Week 41 |
| Hardest-hit age groups | 65+ (274.2 per 100,000); children 5-17 record rate | Early signals point to teens and young adults (G155E) |
Table 2 in the report. Sources: CDC FluView Weeks 17, 20, and 41; Budd (CDC); Becker’s.
5. Early Does Not Mean Severe
The instinct to read an early start as a bad omen is understandable and, on the evidence, mistaken. CDC’s tabulation of seasons from 1982-83 through 2023-24 shows that influenza most often peaked in February (17 seasons), followed by December (seven), January (six), and March (six). Peaks before December are rare: the 2009 pandemic season peaked in October, and CDC’s own review counts one pre-pandemic season that peaked in November. Since the pandemic the calendar has shifted somewhat, with three of five seasons peaking in December, but the peak still falls in winter.
Source: CDC, The Flu Season; Budd, CDC, NAIIS, May 19, 2026. The 2009 pandemic (October) and one pre-pandemic November peak are not shown.
The early starters were not the worst seasons
- 2003-04: a drifted H3N2 and a vaccine CDC called a less-than-optimal match drove positivity above 10 percent by late October; the season was classified moderately severe, with 152 pediatric deaths.
- 2022-23: the “tripledemic” year rose in early October and peaked the week ending December 3, the earliest peak since ILINet began in 1997; it ended with 360,000 hospitalizations, mid-range by any standard.
- 2017-18 and 2024-25: the two most severe seasons of the past decade both peaked in winter rather than autumn.
The Southern Hemisphere points the same way
Australia’s 2025 winter was a record. Its 2026 winter was not. The Immunization Coalition’s tally of laboratory-confirmed notifications stood at 231,473 on October 26, 2026, against more than 410,000 reported by early November 2025, with Queensland down 48 percent. Ian Barr of the WHO Collaborating Center in Melbourne had predicted as much in March, calling two huge years in a row “very unusual.” CDC’s September outlook, informed by 25 experts, rated influenza severity as likely moderate, with “no evidence to indicate that a severe season is more likely” than observed historically.
Source: Immunisation Coalition (NNDSS data to Oct 26, 2026); Murray Pioneer, Nov 9, 2025 (more than 410,000 so far in 2025). The 2025 figure is a reported running total, not a season-end count.
“An early start tells you little about when the season will end or how bad it will be.”
The season is starting earlier than usual but is “still within that window.”
Two caveats
CDC’s outlook was written before the H1N1 surge was visible and does not mention G155E. And an early mild season can still be hard, because it compresses the calendar: a peak arriving in late November coincides with the holiday staffing troughs, overlaps with RSV and COVID-19 seasons that have not yet begun, and leaves room for a second wave in February. Leaders do not need to ask whether this will be a bad season. The question is whether the system can absorb an ordinary one.
11. The Strongest Case Against This Report
The case that this is an ordinary season with an early calendar
- Every official forecast says moderate; CDC’s October data channel rates flu low, COVID-19 declining, RSV very low.
- No relationship in the record between early starts and severe outcomes.
- Neither subclade K nor G155E has been shown to cause more severe illness per infection.
- The vaccine still prevented severe disease last winter, and 93 percent of this year’s H1N1 isolates remain recognized by the vaccine reference virus.
- Hospitals absorbed 710,000 hospitalizations in 2017-18 and again in 2024-25.
- Two consecutive hard winters may have left more population immunity, not less (though the Crick finding concerns H3N2, not G155E).
The case that this report is too calm
- CDC’s outlook predates the H1N1 surge and does not mention the virus now circulating.
- The G155E serology, if it holds, describes an immunity gap in a cohort that is large, mobile, and under-vaccinated.
- A second H3N2 or B wave after the H1N1 peak would hit older adults in February, when hospitals are fullest.
- The surveillance system is weaker than in any recent season: a CDC nearly a third smaller, a wastewater network losing sites, a weekly report warning about its own reporting gaps.
- No federal recommending body, a voluntary insurer pledge, 30 states improvising on pharmacist authority, and measles at 4,588 cases.
- No one declares an emergency for a moderate season, which is precisely when a system with no slack fails.
6 to 8. The Ground It Lands On
What makes this season dangerous is where it lands. Three layers, each thinner than in any recent flu season: the vaccination system, the public health system, and the hospitals that absorb whatever the first two fail to prevent.
6. The Vaccination Gap
CDC’s final coverage estimates for 2025-26 show where the country starts. Children 6 months to 17 years: 51.4 percent, the first increase since the pandemic but still 12.3 points below 63.7 percent in 2019-20. Adults 18 and older: 41.6 percent. Adults 65 and older: 64.4 percent, down from 75.2 percent in 2020-21 and below the 70 percent Healthy People 2030 target. Virginia reported 9.9 percent of residents vaccinated by mid-October, against about 20 percent by the end of October last season.
Source: CDC FluVaxView, Flu Vaccination Coverage, United States, 2025-26 (Oct 8, 2026). Only reported endpoints are drawn; lines connect reported points.
An institutional vacuum
The Advisory Committee on Immunization Practices has not met since December 2025. In June 2025 all 17 members were removed; in March 2026 a federal judge stayed 13 replacement appointments and set aside the reconstituted panel’s votes. CDC lists all three scheduled 2026 meetings as canceled. In place of a formal recommendation, CDC published “interim clinical considerations” on September 1 carrying over the July 2025 recommendations: everyone 6 months and older should be vaccinated, with enhanced vaccines preferred for those 65 and older. AAP, AAFP, ACOG, and IDSA issued their own universal recommendations.
Coverage, trust, and supply
ACA no-cost coverage is tied to ACIP recommendations; insurers pledged in May to keep covering previously recommended immunizations through the end of 2027, a voluntary commitment. KFF counts 30 states that accept other recommending bodies for pharmacist authority. KFF’s October poll found majorities confident in flu vaccine safety, with a partisan gap of roughly 20 points. Supply is not the constraint: up to 135 million doses, all trivalent, and the first generic baloxavir approved in May. Recommendations, trust, and the delivery system have thinned.
7. A Public Health System Running Thin
On October 27, the day after New York’s declaration, CDC confirmed that its deputy director and chief medical officer, Jennifer Shuford, was resigning about four months after starting. The agency she leaves is smaller than the one that managed any recent flu season: 12,705 civil service staff in March 2025 to 8,895 active in May 2026, a loss of roughly 30 percent. In March 2025 HHS terminated about $11 billion in pandemic-era grants to state and local health departments; in February 2026 it ended roughly $600 million more to four states. The National Wastewater Surveillance System’s one-time funding runs out around October 2026, and some sites went dark during a gap between testing contracts.
Sources: Public Data Observatory analysis confirmed by AFGE Local 2883 (CBS News Atlanta, Oct 2, 2026); CDC measles data via Contagion Live, Oct 23, 2026 (2026 through October 22) and CIDRAP.
| Date | Event | Why it matters for this season |
|---|---|---|
| Mar 27, 2025 | HHS restructuring: 82,000 to 62,000 full-time staff; about $11 billion in state and local grants terminated | Epidemiology, lab, and immunization capacity cut as the 2025-26 season approached |
| Jun 2025 | All 17 ACIP members removed and replaced | Begins the chain that leaves no federal flu recommendation for 2026-27 |
| Aug 2025 | CDC Director Monarez ousted | Nearly a year without a confirmed director |
| Feb 2026 | About $600 million in CDC grants to four states ended; states sue | Loss of Public Health Infrastructure Grant positions |
| Mar 16, 2026 | Federal judge stays 13 ACIP appointments and sets aside votes | ACIP cannot meet; all 2026 meetings canceled |
| Aug 5, 2026 | Erica Schwartz confirmed as CDC director, 51-44 | Agency has lost more than 3,000 employees |
| Sep 1, 2026 | CDC interim flu vaccine considerations carry over 2025 recommendations | Universal recommendation stands, but without ACIP’s formal vote |
| Oct 2026 | Wastewater surveillance funding runs out; sites go dark between contracts | Early-warning system degraded as flu arrives early |
| Oct 27, 2026 | CDC deputy director resigns about four months after starting | Leadership turnover during the season’s opening weeks |
| Nov 10-13, 2026 | PAHO review of US measles elimination status | A loss would be the first since the US achieved elimination in 2000 |
Table 3 in the report.
8. Hospitals With No Slack
A UCLA analysis in JAMA Network Open found mean US inpatient occupancy rose from 63.9 percent in 2009 through 2019 to 75.3 percent in 2023-24, while staffed beds fell 16 percent, from about 802,000 to 674,000, with 85 percent projected by 2032. A JAMA study of roughly 492,000 admissions found 53.6 percent boarded in the emergency department four hours or longer. The number of hospitals with pediatric inpatient units fell 29.9 percent between 2008 and 2022. Nursing homes report staff flu vaccination of 42.1 percent, barely half the 80.7 percent in acute care hospitals.
Sources: Leuchter et al., JAMA Network Open, Feb 2025; CDC MMWR 75(15), Apr 23, 2026.
| Indicator | Value | Source |
|---|---|---|
| Mean inpatient occupancy, 2023-24 | 75.3% (63.9% in 2009-2019) | Leuchter et al., JAMA Netw Open |
| Staffed beds | 674,000, down 16% from 802,000 | Leuchter et al. |
| Admitted ED patients boarding 4+ hours | 53.6% | Janke et al., JAMA, Aug 2026 |
| Hospitals with pediatric units, 2008 to 2022 | 1,749 to 1,226 (down 29.9%) | JAMA Pediatrics |
| RN turnover / vacancy, 2026 | 17.6% / 8.6%; ED RN turnover 20.7% | NSI 2026 |
| Rural hospitals vulnerable to closure | 417; 41.2% in the red | Chartis 2026 |
| Nursing home staff flu vaccination, 2024-25 | 42.1% (hospital staff 80.7%) | CDC MMWR, Apr 2026 |
| Mean cost per flu hospitalization | $16,000 (HCUP); $22,849 to $32,231 (commercial claims) | AHRQ; AJMC/Flunomics |
Table 4 in the report.
9. The Price of Being Early
Being early does not multiply flu’s cost. It concentrates it. A peak in late November or December lands on the holiday staffing trough, raises the chance that flu, RSV, and COVID-19 crest together, and displaces the elective procedures that carry the margin. The model below reproduces the report’s worked example for a 300-bed hospital at last winter’s national intensity, then lets you substitute your own figures.
Peak-week flu load calculator
Defaults reproduce Table 5 of the report. Every output is a calculation from the inputs shown; local admission share, length of stay, and payer mix will move every figure.
A hospital running at the national mean moves to roughly 80 percent on flu alone, before RSV, before COVID-19, before the staff who are themselves sick.
Three mechanisms that matter to a hospital’s finances
Timing. A peak in late November or December lands on the holiday staffing trough, when agency labor is scarcest and most expensive. The AHA documented contract nurses rising from 4.7 percent of median nurse labor expense in 2019 to 38.6 percent in January 2022, with billed hourly rates up 213 percent.
Overlap. An early flu peak increases the chance that flu, RSV, and COVID-19 crest together rather than in sequence, as they did in 2022-23.
Displacement. When flu fills medical beds, elective procedures that carry the margin are postponed, as UnityPoint did last winter and California’s hospitals did in 2017-18. A moderate season spread over 16 weeks is a budget line. The same season compressed into eight is a crisis.
| Cost reference | Value | Source |
|---|---|---|
| Mean cost per influenza stay, all payers | $16,000; mean LOS 6.3 days; in-hospital mortality 3.6% | AHRQ HCUP Statistical Brief 253 |
| Cost per admission, commercial claims 2024-25 | $22,849 (65+); $25,113 (18-49); up to $32,231 (high-risk 50-64) | AJMC / Sanofi Flunomics (industry-funded) |
| Annual US economic burden of influenza | $11.2 billion ($3.2B direct medical; $8.0B lost productivity) | Putri et al., Vaccine, 2018 |
| Inpatient cost of 2025-26 at 390,000 hospitalizations | $6.2 billion to $8.9 billion | Calculated from the above |
10. The EARLY Readiness Model
A leader cannot change the virus, the vaccine match, or the federal budget. A leader can change what her organization knows, stocks, staffs, and reaches before the peak. The EARLY Readiness Model organizes those choices into five domains and scores each from 0 to 20. The sum is the Early Season Readiness Index (ESRI) on a 100-point scale. Each criterion met in full scores 5; partially met scores 2 or 3; absent scores 0. Your scores save in this browser so you can repeat the assessment every two weeks through the season.

Early Season Readiness Index scorer
Score each of the 20 criteria. Designed to be completed in an hour by an operations leader with access to the organization’s own data.
Unprepared (below 40)
No local surveillance review, no antiviral standing orders, staff vaccination below 60 percent, no pediatric transfer agreement.
Eyes on the signal 0 of 20
National surveillance is thinner this year, and it was never local. The organizations that saw this season coming were watching their own test positivity and ED visits for influenza-like illness from late August.
Weekly local positivity and ED ILI review with a named owner
Admissions tracked by age group
Subtype and wastewater signal obtained from state or regional sources
Written activation threshold
Antivirals and testing 0 of 20
The strongest single intervention in the hospital's hands is early treatment: an Ontario study of 11,073 hospitalized patients found in-hospital mortality of 3.5 percent with oseltamivir on the day of admission or the next, against 4.9 percent without.
Point-of-care flu testing in ED and urgent care
Standing order for same-day antivirals in high-risk and admitted patients
Antiviral stock verified weekly
Testing and treatment turnaround audited
Reserve capacity 0 of 20
Surge plans fail on the details. In 2022-23, two thirds of overloaded hospitals had a neighbor with open pediatric beds, so regional transfer agreements are worth more than any single hospital's hallway stretchers.
Boarding escalation plan with a four-hour standard
Named elective curtailment triggers
Pediatric and adult transfer agreements
Post-acute discharge acceleration plan
Labor 0 of 20
A vaccinated workforce is a workforce that is present. The hospital benchmark is 80.7 percent; nursing home staff sit at 42.1 percent. Masking triggers should follow the surveillance signal, not a state declaration.
Staff flu vaccination at or above 80 percent
Masking triggers tied to local signal
Agency labor contingency with pre-negotiated rates
Sick-leave coverage plan
Your community 0 of 20
Every admission begins outside the hospital. School-located vaccination in Oakland was associated with 160 fewer flu hospitalizations per 100,000 among adults 65 and older. Nursing home outbreaks become transfers.
Liaison with local health department and schools
Nursing home outbreak communication channel
High-risk patient registry and outreach
Public message that names this year's at-risk population
Index tiers
| Score | Tier | Interpretation |
|---|---|---|
| 80 to 100 | Ready | Signal, treatment, capacity, labor, and community plans are in place and tested; the organization can absorb a moderate season compressed into eight weeks |
| 60 to 79 | Watchful | Most elements exist on paper; one or two domains, usually labor or community, are untested |
| 40 to 59 | Exposed | The organization will know it is in trouble only after boarding exceeds four hours and electives are canceled |
| Below 40 | Unprepared | No local surveillance review, no antiviral standing orders, staff vaccination below 60 percent, no pediatric transfer agreement |
12. What leaders should do now
| Role | This week | Before Thanksgiving | Through the season |
|---|---|---|---|
| Hospital and health system executives | Score the organization on the ESRI; name an owner for each domain below 15 | Confirm antiviral stock, point-of-care testing, elective curtailment triggers, and pediatric transfer agreements | Re-score every two weeks; publish boarding hours to the board |
| Chief nursing and medical officers | Push staff vaccination toward 80 percent; set masking triggers tied to local positivity | Standing orders for same-day antivirals; audit time from test to treatment | Protect sick leave; track staff absence as a leading indicator |
| Emergency department leaders | Activate the four-hour boarding escalation plan now, not at the peak | Rehearse the surge conversion with inpatient and transfer partners | Report boarding daily; escalate at 12 hours without exception |
| Nursing home and post-acute leaders | Staff vaccination campaign; outbreak communication line to referring hospitals | Antiviral prophylaxis protocol ready; accept-back criteria agreed with hospitals | Weekly outbreak status shared with regional hospitals |
| State and local public health officials | Publish declaration thresholds and the data behind them; name the circulating virus | Fund wastewater sites through the season; target vaccination messaging at teens and young adults | Weekly public reporting that does not depend on federal data alone |
| Federal policymakers | Restore ACIP’s ability to meet or designate an interim recommending process | Appropriate dedicated wastewater surveillance funding; stabilize state grants | Rebuild CDC’s epidemiology and immunization staffing before the next season |
Tables 6 and 8 in the report.
Sources and methods
Every quantitative claim on this page is drawn from the report’s 111 numbered references, listed in citation order. The report was researched on October 29, 2026 through four parallel research streams, then fact-checked independently against live sources. An initial framing of the season as driven by H3N2 subclade K was tested against CDC’s Week 41 surveillance data and rejected; the report was reframed around the verified record. Items that could not be verified against a primary source are stated with that caveat: New York’s current-season case counts, Australia’s October subtype, the formal VRBPAC vote outcome, and CDC’s end-of-season vaccine effectiveness for 2025-26. FluView Week 42 is expected October 30 and will supersede the Week 41 figures used here.
- 1New York State Department of Health. New York State Department of Health Announces the Launch of a Comprehensive Seasonal Respiratory Virus Dashboard; Commissioner declares influenza prevalent. Press release, October 26, 2026. Source
- 2New York State Department of Health. New York State Department of Health Declares Flu Prevalent Across the State. Press release, December 2, 2025. Source
- 3New York State Department of Health. New York State Department of Health Declares Flu Is Prevalent Across the State. Press release, December 18, 2024. Source
- 4New York State Department of Health. New York State Department of Health Declares Flu Is Prevalent. Press release, December 6, 2023. Source
- 5WKBW. New York health officials declare flu widespread. December 28, 2016. Source
- 6Erie County Department of Health. Influenza Declared Prevalent in New York State (health advisory citing 10 NYCRR 2.59). December 2023. Source
- 7Centers for Disease Control and Prevention. Weekly US Influenza Surveillance Report: Key Updates for Week 41, ending October 17, 2026. FluView. Source
- 8Centers for Disease Control and Prevention. Weekly US Influenza Surveillance Report: Key Updates for Week 40, ending October 10, 2026. FluView. Source
- 9Centers for Disease Control and Prevention. Weekly US Influenza Surveillance Report: Key Updates for Week 39, ending October 3, 2026. FluView. Source
- 10Centers for Disease Control and Prevention, Center for Forecasting and Outbreak Analytics. 2026-2027 Respiratory Disease Season Outlook. September 23, 2026. Source
- 11Centers for Disease Control and Prevention. Respiratory Illnesses Data Channel. Data as of October 23, 2026. Source
- 12Scott M. Flu cases surge 400% in New York. Democrat and Chronicle via Yahoo News, updated October 28, 2026. Source
- 13CBS6 Albany. New York flu season arrives six weeks early as state tracks new strain. October 27, 2026. Source
- 14Spectrum News. New York State hospitals prepare for early flu season. October 28, 2026. Source
- 15Becker’s Hospital Review. 6 notes on G155E, the mutation fueling an earlier flu season. October 26, 2026. Source
- 16Northeastern University (Northeastern Global News). A mutated flu strain is driving an early season, Northeastern experts say. October 22, 2026. Source
- 17NBC News / TODAY. Flu activity is ramping up early this year. Is a mutated H1N1 strain to blame? October 25, 2026. Source
- 18Advisory Board. Daily Briefing: flu update. October 12, 2026. Source
- 19Becker’s Hospital Review. Seattle Children’s sees early flu surge as US activity climbs. October 5, 2026. Source
- 20FOX 13 Seattle. It’s already here: Western Washington’s early flu season. October 15-16, 2026. Source
- 21Medical Daily. Colorado flu hospitalizations reach 46 in a week (citing CDPHE). October 13, 2026. Source
- 22Medical Daily. Colorado reports first child flu death of 2026-27 season. October 18, 2026. Source
- 23KPEL. Louisiana flu rate double 2025 (citing Louisiana Department of Health). October 13, 2026. Source
- 24Axios. Flu cases rise early; CDC urges shots. October 9, 2026. Source
- 25Centers for Disease Control and Prevention. Weekly US Influenza Surveillance Report: Key Updates for Week 20, ending May 23, 2026. FluView. Source
- 26Centers for Disease Control and Prevention. Weekly US Influenza Surveillance Report: Key Updates for Week 17, ending May 2, 2026. FluView. Source
- 27Centers for Disease Control and Prevention. Weekly US Influenza Surveillance Report: Key Updates for Week 52, ending December 27, 2025. FluView. Source
- 28Budd A. Influenza season update. National Adult and Influenza Immunization Summit, May 19, 2026. Source
- 29Centers for Disease Control and Prevention. Past Seasons Estimated Influenza Disease Burden. Source
- 30Centers for Disease Control and Prevention. 2024-2025 Influenza Season Summary and Vaccination Impact. Source
- 31Centers for Disease Control and Prevention. Estimated Influenza Illnesses, Medical Visits, Hospitalizations, and Deaths in the United States, 2017-2018 Influenza Season. Source
- 32New York State Department of Health. New York State Department of Health Confirms Highest Number of Flu Hospitalizations in a Week. Press release, January 2, 2026. Source
- 33New York State Department of Health. Press release on record weekly flu cases. December 26, 2025. Source
- 34Becker’s Hospital Review. Hospitals postpone elective surgeries as flu strains capacity. January 8, 2026. Source
- 35WXXI News. Unprecedented: Western New York hospitals overwhelmed by influenza A outbreak. January 8, 2026. Source
- 36Advisory Board. Daily Briefing: flu update. January 13, 2026. Source
- 37Maloney SM, et al. Interim Estimates of 2025-26 Seasonal Influenza Vaccine Effectiveness. MMWR Morb Mortal Wkly Rep. 2026;75(9). March 12, 2026. Source
- 38Skowronski DM, et al. Interim influenza vaccine effectiveness against A(H3N2) subclade K, Canada, 2025/26. Euro Surveill. 2026;31(5). February 5, 2026. Source
- 39UK Health Security Agency. Flu vaccine providing important protection despite new subclade. November 11, 2025. Source
- 40Eurosurveillance. Volume 31, Issue 7 (pooled European interim influenza vaccine effectiveness, 2025/26). February 19, 2026. Source
- 41STAT News. Flu season 2026: welcome to the winter of subclade K. January 6, 2026. Source
- 42CSIRO. Super K: what to know about the subclade K flu variant. January 22, 2026. Source
- 43Gavi, the Vaccine Alliance (VaccinesWork). Superflu or same old flu? How subclade K influenza is playing out worldwide. December 19, 2025. Source
- 44Gavi, the Vaccine Alliance (VaccinesWork). How bad will the upcoming flu season be? October 14, 2026. Source
- 45Centers for Disease Control and Prevention. The Flu Season (month of peak activity, 1982-83 through 2023-24). Source
- 46Centers for Disease Control and Prevention. Update: Influenza Activity, United States and Worldwide, 2003-04 Season. MMWR. 2004;53(25). Source
- 47Centers for Disease Control and Prevention. 2022-2023 Influenza Season Summary, Technical Report. Source
- 48Centers for Disease Control and Prevention. 2025-2026 FluSight Evaluation Report. Source
- 49Immunisation Coalition (Australia). Influenza Statistics, NNDSS data to 26 October 2026. Source
- 50ABC News (Australia). Flu season is peaking later than usual and we don’t exactly know why. September 25, 2026. Source
- 51AusDoc. Flu likely back to normal after last year’s strange season, Aussie expert says. March 25, 2026. Source
- 52World Health Organization. Recommendations for influenza vaccine composition for the 2026-2027 northern hemisphere season. February 27, 2026. Source
- 53Centers for Disease Control and Prevention. 2026-2027 Flu Season (vaccine composition and supply). Updated September 29, 2026. Source
- 54Centers for Disease Control and Prevention. Flu Vaccination Coverage, United States, 2025-26 Influenza Season. FluVaxView, October 8, 2026. Source
- 55Cardinal News. State health officials urge Virginians to get flu shots as some states show early surge of infections. October 19, 2026. Source
- 56Centers for Disease Control and Prevention. Interim Clinical Considerations for the Use of Seasonal Influenza Vaccines, 2026-2027. September 1, 2026. Source
- 57Centers for Disease Control and Prevention. ACIP Meeting Information (2026 meetings listed as canceled). Source
- 58NPR. Federal judge halts RFK Jr.’s changes to children’s vaccine policies. March 16, 2026. Source
- 59Reuters (via Cyprus Mail). US appeals court weighs block on Kennedy’s vaccine panel appointments. October 6, 2026. Source
- 60UPI. Doctors issue vaccine advice as CDC stays silent. September 2, 2026. Source
- 61American Academy of Pediatrics (HealthyChildren.org). AAP Flu Prevention and Treatment Recommendations for 2026-27. August 10, 2026. Source
- 62KFF. Recent Changes in Federal Vaccine Recommendations: What’s the Impact on Insurance Coverage? December 16, 2025. Source
- 63Immunize.org. IZ Express, Issue 1877 (AHIP commitment to cover ACIP-recommended immunizations through 2027). June 3, 2026. Source
- 64KFF. KFF Tracking Poll on Health Information and Trust: Fall 2026 Update on Vaccine Views. October 20, 2026. Source
- 65National Foundation for Infectious Diseases. 2026 National Survey on Respiratory Diseases. September 24, 2026. Source
- 66CBS News Atlanta. CDC staffing drops 30% as layoffs, retirements and resignations reshape agency. October 2, 2026. Source
- 67CBS News. Trump administration to shrink federal health agencies by 20,000 employees. March 27, 2025. Source
- 68Healio. Senate confirms Schwartz as CDC director. August 5, 2026. Source
- 69Associated Press (via TheGrio). New CDC director acknowledges exhausted staff at first meeting. August 20, 2026. Source
- 70ABC News. CDC’s deputy director resigns after being hired in April. October 27, 2026. Source
- 71WBUR / WFAE. CDC deputy director resigns as the agency faces mounting criticism. October 28, 2026. Source
- 72Associated Press (via PBS NewsHour). Trump administration’s deep cuts to public health leave system reeling. May 31, 2025. Source
- 73CalMatters. California sues as Trump cuts $600M in public health grants to four states. February 12, 2026. Source
- 74ASTHO. Summary of FY26 Labor-HHS Appropriations Bill. January 2026. Source
- 75The Sick Times. Wastewater testing is vital for public health; it needs sustained funding to continue beyond fall 2026. June 30, 2026. Source
- 76The Sick Times. National COVID-19 trends, October 20, 2026. Source
- 77Contagion Live. Measles Update, October 23, 2026. Source
- 78CIDRAP. US exceeds 1,900 measles cases as outbreaks expand (2025 totals). December 2025. Source
- 79Al Jazeera. Pennsylvania seeks CDC help amid dispute over US measles deaths. September 17, 2026. Source
- 80CNN (via ABC17). Meeting to determine US measles elimination status pushed back to November. March 2, 2026. Source
- 81CNBC. A ‘canary in the coal mine’: Measles resurgence exposes weaknesses in U.S. public health, experts say. October 27, 2026. Source
- 82Leuchter RK, et al. National staffed hospital bed shortage and projected occupancy. JAMA Network Open. February 2025 (via Fierce Healthcare). Source
- 83Becker’s Hospital Review. ED boarding: patients often wait hours for an inpatient team, 7 study notes (Janke et al., JAMA, August 2026). August 17, 2026. Source
- 84Becker’s Hospital Review. Hospitals have lost nearly 30% of pediatric units since 2008 (JAMA Pediatrics). January 21, 2025. Source
- 85Becker’s Hospital Review. The cost of nurse turnover in 10 points, 2026 (NSI Nursing Solutions). April 22, 2026. Source
- 86Chartis. 2026 Rural Health State of the State. February 10, 2026. Source
- 87Becker’s Hospital Review. Hospital closures slow in 2026: a calm before the storm? September 30, 2026. Source
- 88Yale News. During tripledemic, some hospitals overflowed while others had empty beds (JAMA Network Open). October 9, 2025. Source
- 89Centers for Disease Control and Prevention. Influenza and COVID-19 vaccination coverage among nursing home residents and staff, 2024-25. MMWR. 2026;75(15). April 23, 2026. Source
- 90Agency for Healthcare Research and Quality. HCUP Statistical Brief 253: Influenza-related hospitalizations and emergency department visits, 2006-2016. October 2019. Source
- 91American Journal of Managed Care. Older adults drive hospitalizations, costs in the US 2024-2025 influenza season (Sanofi Flunomics). November 24, 2025. Source
- 92Putri WCWS, Muscatello DJ, Stockwell MS, Newall AT. Economic burden of seasonal influenza in the United States. Vaccine. 2018;36(27):3960-3966 (as summarized in medRxiv preprint, December 2025). Source
- 93American Hospital Association. Massive Growth in Expenses and Rising Inflation Fuel Continued Financial Challenges for America’s Hospitals and Health Systems. April 2022. Source
- 94CHEST Physician. Oseltamivir beats supportive care for patients hospitalized with seasonal influenza (Bai et al., JAMA Network Open, 2025). August 20, 2025. Source
- 95CIDRAP. Analysis finds limited evidence for HCW flu vaccination (summary of CDC meta-analysis and Cochrane review). Source
- 96UC Berkeley School of Public Health. School flu vaccine program reduces community-wide influenza hospitalizations (PLOS Medicine). August 18, 2020. Source
- 97Los Angeles County Department of Public Health. Respiratory Virus Season Health Officer Order. Source
- 98Denver7. A Colorado hospital brought back mask mandates as flu hospitalizations surged. January 30, 2026. Source
- 99Skilled Nursing News. CMS, states partner to launch $275M nursing home workforce initiative. October 23, 2026. Source
- 100CSL Seqirus. CSL Seqirus expands US availability of influenza vaccine following successful completion of the 2026/27 manufacturing campaign. PR Newswire, September 29, 2026. Source
- 101U.S. Pharmacist. FDA approves first generic single-dose influenza treatment. May 19, 2026. Source
- 102Beth Israel Deaconess Medical Center. Influenza strain partially dodges existing immunity and current vaccine, BIDMC-led study finds (JAMA research letter, March 10, 2026). Source
- 103Centers for Disease Control and Prevention. 2014-2015 Flu Season Wrap-Up (H3N2 seasons and older adults). Source
- 104New York State Department of Health. Press release on COVID, influenza and seasonal immunizations (2025-26 toll: nearly 27,000 hospitalized, nearly 600 deaths). October 9, 2026. Source
- 105CVS Health. CVS Pharmacy and MinuteClinic now offering updated flu vaccines nationwide (survey of vaccination intent). Press release, August 27, 2026. Source
- 106Centers for Disease Control and Prevention. Weekly US Influenza Surveillance Report: Key Updates for Week 2, ending January 10, 2026. FluView. Source
- 107KFF. Tracking State Actions on Vaccine Policy and Access. Updated August 11, 2026. Source
- 108Fortune. The tripledemic is sickening kids across the U.S.; hospitals are getting creative with capacity. November 8, 2022. Source
- 109Murray Pioneer. Record-breaking flu numbers as vaccination rates stall. November 9, 2025. Source
- 110ASTHO. Summary of FY27 Continuing Resolution. September 2, 2026. Source
- 111Healthcare Dive. Flu season on track to be worst in a decade; California hospitals cancel surgeries and triage in tents. January 30, 2018. Source
Showing 111 of 111 references.
No part of this report constitutes medical advice. Vaccination and treatment decisions belong to patients and their clinicians.